IL122774A0 - Neurturin and related growth factors - Google Patents

Neurturin and related growth factors

Info

Publication number
IL122774A0
IL122774A0 IL12277496A IL12277496A IL122774A0 IL 122774 A0 IL122774 A0 IL 122774A0 IL 12277496 A IL12277496 A IL 12277496A IL 12277496 A IL12277496 A IL 12277496A IL 122774 A0 IL122774 A0 IL 122774A0
Authority
IL
Israel
Prior art keywords
neurturin
methods
growth factors
vectors
human
Prior art date
Application number
IL12277496A
Other languages
English (en)
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of IL122774A0 publication Critical patent/IL122774A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL12277496A 1995-08-28 1996-08-27 Neurturin and related growth factors IL122774A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/519,777 US5739307A (en) 1995-08-28 1995-08-28 Polynucleotide encoding neurturin neurotrophic factor
PCT/US1996/014065 WO1997008196A1 (en) 1995-08-28 1996-08-27 Neurturin and related growth factors

Publications (1)

Publication Number Publication Date
IL122774A0 true IL122774A0 (en) 1998-08-16

Family

ID=24069730

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12277496A IL122774A0 (en) 1995-08-28 1996-08-27 Neurturin and related growth factors

Country Status (12)

Country Link
US (6) US5739307A (de)
EP (1) EP0787142B1 (de)
JP (1) JP4222629B2 (de)
AT (1) ATE315578T1 (de)
AU (1) AU714107B2 (de)
CA (1) CA2194172C (de)
DE (1) DE69635738T2 (de)
DK (1) DK0787142T3 (de)
IL (1) IL122774A0 (de)
MX (1) MX9800277A (de)
NZ (3) NZ332921A (de)
WO (1) WO1997008196A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743628B1 (en) * 1995-08-28 2004-06-01 Washington University Method of cell culture using neurturin
US6184200B1 (en) 1995-09-28 2001-02-06 Amgen Inc. Truncated glial cell line-derived neurotrophic factor
US6716600B1 (en) 1996-03-14 2004-04-06 Washington University Persephin and related growth factors
AU716846B2 (en) 1996-03-14 2000-03-09 Washington University Persephin and related growth factors
US6222022B1 (en) 1996-03-14 2001-04-24 Washington University Persephin and related growth factors
IL129851A0 (en) 1996-11-15 2000-02-29 Genentech Inc Purification of neurotrophins
WO1998046622A1 (en) * 1997-04-17 1998-10-22 Washington University RECEPTORS FOR TGF-β-RELATED NEUROTROPHIC FACTORS
US7723473B2 (en) * 1997-06-19 2010-05-25 St. Louis University Peptide antagonists of TGF-beta family members and therapeutic uses thereof
SI1005358T1 (en) * 1997-07-30 2003-06-30 Amgen Inc. Use of a neurturin protein product for preventing and treating hearing loss
US6043221A (en) * 1997-07-30 2000-03-28 Amgen Inc. Method for preventing and treating hearing loss using a neuturin protein product
US6593133B1 (en) 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
US7067473B1 (en) * 1998-07-14 2006-06-27 Janssen Pharmaceutica N.V. Neurotrophic growth factor
JP4469500B2 (ja) * 1998-07-14 2010-05-26 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 神経栄養成長因子
US6268352B1 (en) * 1998-09-02 2001-07-31 The Regents Of The University Of California Promoters of neural regeneration
US20020002269A1 (en) * 1998-09-29 2002-01-03 Jeffrey D. Milbrandt Artemin, a neurotrophic factor
WO2000024415A2 (en) * 1998-10-28 2000-05-04 Cornell Research Foundation, Inc. Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
PT1175433E (pt) 1999-05-04 2005-11-30 Strakan Int Ltd Glicosidos androgenos e sua actividade androgenica
JP2002543841A (ja) * 1999-05-17 2002-12-24 バイオファーム ゲゼルシャフト ツア バイオテクノロジシェン エントヴィックルング ウント ツム フェルトリーブ フォン ファルマカ エムベーハー ＴＧＦ−βスーパーファミリーの新規のメンバーであるＧＤＦ―１５の神経保護特性
US7592433B1 (en) * 1999-11-05 2009-09-22 The University Of Queensland; Hexima Limited Polynucleotides encoding cyclotide-like structures
US6866851B1 (en) 1999-12-28 2005-03-15 Washington University GFRα1-RET specific agonists and methods therefor
GB0024550D0 (de) 2000-10-06 2000-11-22 Oxford Biomedica Ltd
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7276580B2 (en) 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
WO2002078730A2 (en) 2001-03-28 2002-10-10 Biogen, Inc. Use of neublastin polypeptides for treating neuropathic pain
US7658926B2 (en) * 2001-09-14 2010-02-09 Opexa Pharmaceuticals, Inc. Autologous T-cell vaccines materials and methods
WO2003099318A2 (en) 2002-05-29 2003-12-04 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung Pancreas-specific proteins
US20050222070A1 (en) * 2002-05-29 2005-10-06 Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung Pancreas-specific proteins
EP2363710B1 (de) * 2002-08-08 2015-07-01 Baylor College Of Medicine Isolierung und identifizierung von t-zellen
WO2004094592A2 (en) 2003-04-18 2004-11-04 Biogen Idec Ma Inc. Polymer-conjugated glycosylated neublastin
WO2004104172A2 (en) * 2003-05-15 2004-12-02 Bioarray Solutions, Ltd. Hybridization-mediated analysis of polymorphisms
AU2004245175C1 (en) 2003-06-10 2010-03-18 Biogen Ma Inc. Improved secretion of neublastin
CN1867678B (zh) * 2003-09-12 2012-10-03 干细胞技术公司 神经集落形成分析
US7598059B2 (en) 2003-10-02 2009-10-06 Biogen Idec Ma Inc. Neublastin expression constructs
BRPI0415563A (pt) 2003-10-20 2007-01-02 Nsgene As método para o tratamento do mal de parkinson, uso de um vetor viral, vetor de expressão viral, composição farmacêutica, célula hospedeira isolada, linhagem de células de empacotamento, mamìfero não humano quimérico, dispositivo de cultura celular implantável, cápsula biocompatìvel, método para tratamento de uma doença do sistema nervoso, célula de mamìfero, e, método para produzir neurturin ou um seu equivalente funcional
PL1694354T3 (pl) 2003-11-27 2009-12-31 Develogen Ag Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny
NZ553420A (en) 2004-08-19 2010-02-26 Biogen Idec Inc Refolding transforming growth factor beta family proteins
KR20110126732A (ko) 2004-08-19 2011-11-23 바이오겐 아이덱 엠에이 인코포레이티드 뉴블라스틴 변형체
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
EP2420833B1 (de) * 2006-05-05 2015-09-02 Opexa Therapeutics T-Zell Vakzin
EP1872790A1 (de) 2006-06-26 2008-01-02 DeveloGen Aktiengesellschaft Neue Zusammensetzung zur Erhöhung der Bioverfügbarkeit von Neurturin
ES2476253T3 (es) 2007-05-01 2014-07-14 Biogen Idec Ma Inc. P�ptidos de neublastina para su uso en el aumento de la vascularizaci�n en tejido con flujo sanguíneo deteriorado
EP2192904B1 (de) 2007-08-27 2016-08-17 Auxagen, Inc. VERFAHREN ZUR HEMMUNG VON TGF-beta
CA2742839A1 (en) * 2007-11-05 2009-05-14 Develogen Aktiengesellschaft Novel neurturin conjugates for pharmaceutical use
US8487006B2 (en) 2008-09-16 2013-07-16 Auxagen, Inc. Method of enhancing TGF-β signalling
BR112012009801A8 (pt) * 2009-10-30 2016-08-30 Cns Therapeutics Inc Polipeptídeo neurturina e variante de neurturina
US9127083B2 (en) 2009-10-30 2015-09-08 Ntf Therapeutics, Inc. Neurturin molecules
US8445432B2 (en) 2009-10-30 2013-05-21 Ntf Therapeutics Inc Neurturin molecules
US8564522B2 (en) * 2010-03-31 2013-10-22 Apple Inc. Reduced-power communications within an electronic display
NZ704191A (en) 2010-06-14 2016-05-27 Hoffmann La Roche Cell-penetrating peptides and uses therof
EP2394665A1 (de) * 2010-06-14 2011-12-14 F. Hoffmann-La Roche AG Zellenpenetrierende Peptide und Verwendungen davon
US9869272B1 (en) 2011-04-20 2018-01-16 Martin A. Stuart Performance of a transcritical or supercritical CO2 Rankin cycle engine
EP2594295A1 (de) 2011-11-16 2013-05-22 Servicio Andaluz De Salud Nervenimplantat basierend auf einem kompaktierten, zellhaltigen Biomaterial
JP2019502674A (ja) * 2015-08-25 2019-01-31 ヒスタイド アクツィエンゲゼルシャフト 組織形成誘導用化合物及びその使用
AU2016311298A1 (en) 2015-08-25 2018-02-08 Histide Ag Compounds for inducing tissue formation and uses thereof
BR112018071215A2 (pt) 2016-04-13 2019-02-19 Universiteit Maastricht peptídeo para uso no tratamento, melhora ou prevenção de osteoartrite

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141856A (en) * 1989-01-05 1992-08-25 Synergen, Inc. Expression of purified ciliary neurotrophic factor
US5011914A (en) * 1989-01-05 1991-04-30 Collins Franklin D Purified ciliary neurotrophic factor
US5260417A (en) * 1989-04-03 1993-11-09 Genetics Institute, Inc. Megakaryocyte growth promoting activity protein
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
WO1993000616A1 (en) 1991-06-29 1993-01-07 Kao Corporation Method of forming fixed images
HU220795B1 (hu) * 1991-09-20 2002-05-28 Amgen Inc. Gliasejtvonal-eredetű neurotróf faktorfehérjék, továbbá berendezések és gyógyászati készítmények idegsejtkárosodás megelőzésére és kezelésére
CA2170751A1 (en) * 1993-09-01 1995-03-09 Timothy J. Cunningham Neuron regulatory factor for promoting neuron survival
WO1995017203A1 (en) * 1993-12-22 1995-06-29 The University Of Medicine And Dentistry Of New Jersey Novel nucleic acid sequences isolated from glial cells
US5759775A (en) * 1994-10-27 1998-06-02 Genetech, Inc. Methods for detecting nucleic acids encoding AL--1 neurotrophic factor
AU716846B2 (en) * 1996-03-14 2000-03-09 Washington University Persephin and related growth factors

Also Published As

Publication number Publication date
DK0787142T3 (da) 2006-05-29
AU7105496A (en) 1997-03-19
EP0787142A1 (de) 1997-08-06
US7015311B1 (en) 2006-03-21
DE69635738D1 (de) 2006-04-06
ATE315578T1 (de) 2006-02-15
DE69635738T2 (de) 2006-08-31
NZ332922A (en) 1999-07-29
EP0787142A4 (de) 1999-04-07
US5843914A (en) 1998-12-01
EP0787142B1 (de) 2006-01-11
WO1997008196A1 (en) 1997-03-06
NZ332921A (en) 2001-03-30
US5739307A (en) 1998-04-14
US6090778A (en) 2000-07-18
MX9800277A (es) 1998-09-30
CA2194172A1 (en) 1997-03-01
JP4222629B2 (ja) 2009-02-12
US5817622A (en) 1998-10-06
US5747655A (en) 1998-05-05
AU714107B2 (en) 1999-12-16
NZ318939A (en) 1999-01-28
JPH11512928A (ja) 1999-11-09
CA2194172C (en) 2012-07-10

Similar Documents

Publication Publication Date Title
IL122774A0 (en) Neurturin and related growth factors
EP0861894A4 (de) Polypeptid, das die differenzierung unterdrueckt
AU2681497A (en) Novel agouti-related gene
BG109433A (en) RET (RetL) Lead for Stimulating Nerve and Rat Growth
EP2189475A3 (de) Fibroblasten wachstumsfaktor-ähnliche Polypeptide
PL331005A1 (en) Regulating dna of hamster's ef-1alpha transcription
Neuhaus et al. The human connexin32 gene is transcribed from two tissue-specific promoters
Luka et al. Mutations in human glycine N-methyltransferase give insights into its role in methionine metabolism
EP0886651A4 (de) Persephin und verwandte wachstumsfaktoren
GR3034772T3 (en) Growth differentiation factor-12
IL133834A0 (en) Persephin and related growth factors
AU633896B2 (en) Method of detecting small cell carcinoma and use of acyl-peptide hydrolase and coding sequences therefor
Chiannilkulchal et al. A primary expression map of the chromosome 15q15 region containing the recessive form of limb-girdle muscular dystrophy (LGMD2A) gene
NZ334970A (en) Human growth gene and short stature gene region using sequence derived from the SHOX gene
WO2000008157A3 (en) Human anion transporter genes atnov
Chuang et al. Molecular cloning of the mature E1b-β subunit of human branched-chain α-keto acid dehydrogenase complex
Falaschi et al. The three DNA polymerases of animal cells: properties and functions
RU2003123108A (ru) Мутантные формы человеческого белка fgf23, снижающие содержание фосфора в крови
AU7610396A (en) Connective tissue growth factor-3
Yamada et al. p33, an endogenous target protein for arginine‐specific ADP‐ribosyltransferase in chicken polymorphonuclear leukocytes, is highly homologous to mim‐1 protein (myb‐induced myeloid protein‐1)
Li et al. Cloning and sequence analysis of two embryonic β-like globin cDNAs (y and z) of hamster
EP0787798A3 (de) GRP17 Gen
DE69942723D1 (de) Menschliches tsc403 gen
WO1999043834A3 (en) P-selectin ligand protein, including tetrameric fusion proteins
Berger et al. Demonstration of thymopoietin transcripts in different hematopoietic cell lines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired